IPO · IPSC
Century Therapeutics, Inc.
Century Therapeutics, Inc. (IPSC) priced its initial public offering on Jun 21, 2021 at $20.00 per share, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $1.1B. J.P. Morgan was lead-left underwriter, joined by BofA Securities, Leerink Partners and Piper Sandler. Davis Polk advised the underwriters.
- Status
- IPO
- Ticker
- IPSC
- Exchange
- Nasdaq Global Select
- Priced
- Jun 21, 2021
- IPO price
- $20.00
- Market cap at IPO price
- $1.1B
- First filed
- May 28, 2021
- Underwriters
- J.P. Morgan, BofA Securities, Leerink Partners and Piper Sandler
- Underwriters' counsel
- Davis Polk
- Sector
- Biotech & pharma
- Country / state
- PA
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
- Shares offered, over-allotment and shares outstanding after the offering
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed May 28, 2021
- Latest amendment Jun 15, 2021
- Final prospectus (424B4) Jun 21, 2021
- All filings on EDGAR CIK 1850119
Other Biotech & pharma IPOs in 2021
- Miromatrix Medical Inc.MIRO · Jun 24, 2021 · $43.2M
- iSpecimen Inc.ISPC · Jun 21, 2021
- Atai Beckley N.V.ATAI · Jun 21, 2021 · $225M
- Ambrx Biopharma Cayman, Inc.AMAM · Jun 21, 2021 · $126M
- Cyteir Therapeutics, Inc.CYT · Jun 21, 2021 · $133.2M
- Lyell Immunopharma, Inc.LYEL · Jun 21, 2021 · $425M